Highlights Roche Holding AG

Equities

ROG

CH0012032048

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:31:09 10/12/2025 GMT			5-day change	1st Jan Change
322.00 ^CHF	+2.12%		+2.78%	+26.03%

02:12pm	Roche Says Breast-Cancer Drug Shows Potential to Become Standard-Of-Care	DJ
01:18pm	Roche breast cancer pill cuts risk of disease recurrence by 30% in trial	RE

Highlights

Roche breast cancer pill cuts risk of disease recurrence by 30% in trial	01:18pm	RE
Roche Launches New PCR Test for Vaginitis After Securing CE Mark	12-09	MT
Roche's Active Lupus Nephritis Treatment Receives EU Approval	12-09	MT
Roche Launches New PCR Test to Help Improve Diagnostic Accuracy for Women Affected by Vaginitis in Countries Following the Ce Mark	12-09	CI
European Commission Approves Gazyva/Gazyvaro for Adults with Active Lupus Nephritis	12-09	CI
Roche Presents Lunsumio Data Showing Potential Across Earlier Treatment Lines in Indolent and Aggressive Lymphomas	12-08	CI
Brightening Consumer Sentiment Lifts Swiss Market Index	12-08	MT
Weight-loss drug developers line up to tap lucrative market as competition heats up	12-08	RE
Roche's Columvi Combination Shows Sustained Survival Benefit At Three-Year Follow Up of Pivotal Phase Iii Starglo Study	12-08	CI
Swiss stocks - Factors to watch on December 8	12-08	RE
Orano Med Enters Next Phase of Collaboration with Roche	12-04	CI
US FDA Green-lights Roche's First Point-of-care Test for Whooping Cough	12-02	MT
Berenberg Ups Roche Price Target Amid Upside Pipeline Surprise, Expected 'Solid' Momentum	12-02	MT
Roche Receives FDA Clearance with CLIA waiver and CE Mark for its First Point-Of-Care Test for Diagnosing Bordetella Infections, Including Whooping Cough	12-02	CI
STOXX 600 ends steady after multiple-session rally; Puma, Allfunds jump on takeover buzz	11-27	RE
UK Regulator Approves Roche's Targeted Treatment for Advanced Breast Cancer	11-26	MT
Weight-loss drug developers line up to tap lucrative market as competition heats up	11-25	RE
Kalivir Immunotherapeutics, Inc. Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Vet3-Tgi in Combination with Atezolizumab (Tecentriq®?) in Advanced Solid Tumors	11-19	CI
Roche Obtains Conditional Marketing Permit in EU for Lymphoma Treatment Lunsumio Subcutaneous	11-19	MT
European Commission Approves Roche's Lunsumio Subcutaneous for Relapsed or Refractory Foothicular Lymphoma	11-19	CI
Health Care Up After Strong Earnings -- Health Care Roundup	11-18	DJ
Swiss Market Index Closes Lower; Roche Shares Up	11-18	MT
Roche's Giredestrant Becomes the First Oral SerD to Show Superior Invasive Disease-Free Survival in Early Breast Cancer	11-18	CI
Roche oral drug shown to keep breast cancer at bay, boosting shares	11-18	RE
Rovi and Roche sign final agreement for manufacture of new medicine	11-18	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ROCHE HOLDING : Markets need more proof of potential; guidance upgrade apparently won't cut it

October 23, 2025 at 04:05 pm

Roche will invest $50bn in US over five years.

April 22, 2025 at 09:49 am

Roche CEO 'Very Confident' on Outlook, Momentum

October 23, 2024 at 09:07 am